Antiretroviral adherence among HIV-infected patients has become critical in the treatment of HIV. It is of particular concern among older HIV patients who may be more susceptible to faster progression of disease (1) , have been noted to have shorter survival periods with HIV (2) , are often on increased numbers of medications for concomitant diseases, and may often receive inappropriate medications (3, 4) . Although few adherence studies have been specifically conducted on older HIV patients, studies of general medication use among older patients with other disease states may provide insight regarding adherence behavior with HIV medications. This article reviews studies highlighting the importance of antiretroviral adherence and further assesses several methods that have been used to measure antiretroviral adherence. In addition, it details various factors that have been linked to medication adherence in both HIV disease and other diseases affecting older populations. Finally, this work discusses the interventions that have been implemented in various disease states that may have implications for the improvement of adherence in the older HIV population.
ANTIRETROVIRAL THERAPY
Improvements in the survival of HIV-infected adults have been attributed to various factors, including earlier diagnosis of HIV disease, greater access to medical care, and development of therapeutic strategies to limit replication of HIV (5) (6) (7) . Nevertheless, it is increasingly clear that the therapeutic benefits of highly active antiretroviral therapy (HAART) are strongly dependent on stringent patient adherence to these regimens (8) (9) (10) . The ultimate goal of HAART is to reduce viral load to an undetectable level (11) . Unfortunately, the initial promise of HAART therapy has been moderated by the high incidence of medication-related side effects and the development of drug mutations to protease inhibitors (PIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and nucleoside reverse transcriptase inhibitors (NRTIs). These powerful therapeutic agents have been associated with undesirable side effects that have made the regimens difficult to tolerate. Most of the drugs may cause nausea, vomiting, and diarrhea, and the regimens include a high pill burden (12, 13) . Furthermore, long-term complications of HAART agents have included the following: lipodystrophy, glucose intolerance, and hypertriglyceridemia (Table 1) (14, 15) . More alarmingly, researchers have documented the development of antiretroviral-resistant strains of HIV (16) . These factors highlight the difficult nature of treating HIV disease; patients must be encouraged to maintain high levels of adherence to medication regimens that are difficult to maintain. Furthermore, although there have been few studies that have specifically evaluated antiretroviral adherence among older HIV-infected adults, studies among younger and middle-aged HIV-infected adults may certainly provide meaningful data.
The importance of antiretroviral adherence has been further highlighted by a study by Paterson et al. (9) noting that adherence to HAART must exceed 95% to limit viral replication effectively. These authors reported that among the patients evaluated in their study, patients with less than 80% medication adherence had an 87% virologic failure rate, whereas patients with medication adherence ranging from 80% to 90% reported a virologic failure rate of 47%. Patients with an adherence rate more than 95% had a 10% virologic failure rate. In another study conducted specifically among older HIV-infected adults, Wutoh et al. (17) reported a significant inverse correlation between antiretroviral adherence and viral load among 100 HIV-infected adults older than 50 years of age. Estimates of antiretroviral adherence among HIV-infected patients have ranged from 0% to 100%, with decreased adherence clearly associated with increased HIV viral load (8) (9) (10) (11) 17) , thus highlighting the scope of the problem as well as the need for additional research in various populations.
ADHERENCE OR COMPLIANCE
Adherence generally refers to the quantified level to which an individual follows a prescribed treatment regimen. Compliance, although related to adherence, evaluates "the extent to which the patient's behavior coincides with medical or health advice" (18) . Compliance has often been evaluated as a dichotomous description of treatment behavior (i.e., compliant or noncompliant). The use of the term compliance has lost favor in sociobehavioral research in large part because of the perception of a value judgment being placed on a patient's medication-taking behavior (18, 19) . Low levels of adherence may adversely affect patient outcomes and result in rapid rebound of plasma viremia, development of resistant strains of HIV, more rapid immune deterioration, and quicker progression to AIDS and death (20, 21) .
ADHERENCE MEASUREMENT
Unfortunately, measurement of antiretroviral adherence is limited by the lack of a "gold standard," thus making evaluation of adherence an imperfect science (22) . The most frequently applied methodology in the measurement of adherence is patient self-report. Although this is often the most facile way of obtaining adherence information, the literature is replete with reports of the unreliable nature of self-reported medication-taking behavior (9, 10, 23) . Recent studies have suggested potentially large discrepancies between patient self-report and other concurrent measures of adherence (9, 24) . For example, Bangsberg et al. (25) evaluated adherence to PI therapy among a group of HIV-infected patients using self-report, pill count, and electronic medication monitoring. The median adherence reported ranged widely depending on which adherence measure was assessed, although adherence explained 36% to 65% of the variation in concurrent HIV RNA levels. Median adherence was highest using self-report and lowest using electronic monitoring. The authors also concluded that a strong relationship was found between independent methods of adherence measurement and concurrent viral suppression. In addition to potential overestimation of actual adherence, self-reported adherence is limited in that data may only reflect short-term or mean adherence.
Pill counts often are used by investigators as a more objective means of evaluating medication adherence behavior. This method requires that patients return medications to the study center or clinician for assessment. Several studies have noted patients engaging in "pill dumping" as a means of preventing acknowledgment of poor adherence behavior (26) . Use of electronic monitoring devices to assess adherence behavior has been increasing. These devices, including the Medication Event Monitoring System (MEMS; AARDEX USA, APREX, a division of AARDEX, Union City, CA), consist of a computer chip embedded within a medication cap that records the opening and closing of a medication vial. This technology has several limitations, however, including the need for accompanying technology to interpret the readings of the computer chip, patient acceptance and accurate use of the computerized caps, increased costs, and inaccurate interpretations if multiple doses are removed at once. Some antiretroviral medications are chemically and economically suitable for chemical assay. Nevertheless, this method is not readily available for all antiretrovirals and may only provide meaningful results relating to the consumption of the most recent doses of medication. This is not necessarily practical for all patients or researchers (27, 28) . Physician and other health care provider estimates of patient medication behavior also have proven to predict actual patient adherence poorly (25) . In a study of 45 patients, Bangsberg et al. (29) noted that 13% of patients were not following their regimens as prescribed. Whereas provider adherence estimate explained only 26% of the variation in pill count adherence, patient report explained 72% (29) . Clinical markers such as viral load have often been used to validate other adherence measures (8, 17, 25) . Additional methods to assess adherence include evaluation of pharmacy refill records, patient diaries, and direct observed therapy (DOT) (23, 24, 29) . These methods typically require comparisons to self-report, however (29) . The most reliable approach is likely to combine self-report, electronic monitoring, pill counts, and/or various other combinations of approaches (9) . Table 2 contains a comparison of the various adherence measurement methods.
FACTORS AFFECTING ADHERENCE General Medication Adherence Among Older Adults
Studies have shown that medication adherence among patients aged 60 years or older ranges from 26% to 68% (30) (31) (32) (33) . Although some studies find that age is positively associated with adherence (34, 35) , most of the literature has shown that it is not age specifically that relates to adherence but the factors commonly related to aging (e.g., polypharmacy, cognitive and physical limitations, social isolation, and access to affordable services) that are often predictive of adherence (36) (37) (38) (39) (40) (41) (42) . For example, Balkrishnan's review (37) of medication use in the elderly revealed that age-related factors such as number of medications, cost burden, and insurance coverage all were related to adherence. Other factors related to adherence among older adults include knowledge of the regimen, importance of taking the medications, less fear about illness, increased psychologic distress, ability to read the label, understanding of physician's directions or poor physician-patient communication, less belief in powerful others (e.g., health care professionals), and living with a spouse or relative (36, 42) .
Antiretroviral Adherence
Although few specific antiretroviral adherence studies have been conducted in older patients with HIV, several socio-behavioral factors have been related to antiretroviral adherence behavior among HIV-infected adults, including active alcohol or drug use (43) (44) (45) . It must be noted that the interaction between illicit drug use and adherence may be complex. Broers et al. (46) found that injection drug users tend to access medical care later in their disease course than other individuals. Nevertheless, once receiving antiretroviral therapy, injection drug users had comparable compliance when compared with patients from other HIV risk groups. Another study by Lerner et al. (47) reported that substance abuse did not predict antiretroviral adherence. This is often the case, particularly if substance abuse is not current or active. Several studies have noted a consistent association between depression and decreased adherence (48-52). Hirschhorn et al. (52) noted an association between depression and decreased adherence, particularly in relation to unstable housing. Unstable housing also has been reported as an independent predictor of decreased adherence, although one study of a cohort of 132 homeless male subjects noted that of the 22% taking PIs, 80% of these individuals reported taking more than 90% of their prescribed doses (53) . Self-report in this study was consistent with plasma blood levels taken of PIs.
Other studies also have reported racial and ethnic variations in antiretroviral adherence. Singh et al. (54) reported that nonwhite patients were less likely to be adherent compared with white patients. This difference was not explained by age, education, employment, income, history of injection drug use, or medical regimen. The authors concluded that patient satisfaction with social support and coping style also varied significantly by race and was likely to explain the observed racial difference in adherence. Siegel et al. (55) reported that among older HIV-infected men, black men expressed significantly more doubt regarding their ability to use PIs and to adhere to PI treatment compared with white men. The authors also noted significant differences in self-efficacy between black and white men. Kemppainen et al. (56) reported that among 52 male veterans included in their study, factors influencing antiretroviral adherence included ethnicity, age, and intravenous drug use, because nonwhite patients were most influenced by positive support from others to improve medication adherence behavior.
Gender also has been associated with antiretroviral adherence, because male gender seems to be related to decreased adherence (57) . This pattern holds true for black men, who have been shown in several studies to be less likely to adhere to antiretrovirals (55, 58) . In subpopulations of women, there have been interesting attitudinal studies of adherence behavior. For example, Mostashari et al. (59) conducted structured interviews of 102 HIV-infected female prisoners. Among these women, acceptance of antiretrovirals was associated with nonblack race, trust in medication safety, and lower education level. Medication adherence was correlated with patient-physician relationship and presence of emotional support. Interestingly, age also has been positively correlated with increased adherence (60). Mehta et al. (57) noted an association between adherence and age, especially in male patients. A review of several adherence studies by Chesney et al. (61) noted a frequent association between younger age and decreased adherence in the studies reviewed.
The HIV Cost and Services Utilization Study (HCSUS) reported that perceptions that antiretrovirals are effective and that nonadherence leads to viral resistance were predictive of higher adherence (61) . Other factors that have been associated with decreased adherence include the following: lower levels of education, anxiety, pain, pill burden, lack of convenient access to medication, side effects, and dissatisfaction with the health care system (9, 26, 48, 49) . The potential for drugdrug interactions is of particular concern in older patients, particularly because many of them are already under treatment of existing comorbidities (3, 4) . Table 2 provides a listing of the potential side effects and selected adverse drug reactions associated with antiretroviral therapy.
Antiretroviral Adherence in Older Patients
A few studies have investigated antiretroviral adherence among older HIV-infected adults (17, 55, 56) . As noted earlier, Siegel et al. (55) conducted qualitative interviews with 49 older adults (aged 50-67 years) to determine the main factors relating to nonadherence. Among the factors listed by patients were side effects, busy schedules, fatigue, and stigmatization of HIV. The authors concluded that age-related issues, including complex regimens and visual and cognitive impairment, were not major factors regarding nonadherence with these patients. In a study of male veterans, Kemppainen et al. (56) identified several categories of variables that may influence adherence, including development of a medication adherence plan, motivation to take medication, medication requirements and dosing schedule, response to HIV/AIDS, social support, and reminders.
INTERVENTIONS
Regarding interventions, no single approach to improve adherence behavior is considered penultimate. Strategies for use with older populations are likely to include clinician approaches, patient-related methods, and medication-related means (27) . A combination of approaches is necessary for most patients, with the cornerstone of these strategies resting on patients' comfort level with practitioners (45, 62) . For example, patients with trusting physician relationships have reported higher adherence (45). Bertholon et al. (63) noted that patients feel most comfortable discussing medication regimens and treatment strategies with their physicians and other health care providers. That the patient and/or caregiver has a good understanding of the treatment plan and the importance of adherence is essential. Gaining this understanding may require several conversations with physicians, pharmacists, nurses, and other members of the health team (64) . Additionally, patients with established support systems, including family, friends, and community groups, are more likely to adhere to treatment (65, 66) .
McPherson-Baker et al. (67) have reported that exposure to counseling and behavioral interventions proved effective in increasing adherence in a sample of HIVinfected men. They found that patients should be integrally involved in the process of selection and administration of antiretroviral therapy. The antiretroviral regimen, potential side effects, and any special instructions regarding the medication should be explained thoroughly to the patient. Furthermore, storage instructions and a dosing schedule should be discussed. If the patient experiences side effects or has difficulty in maintaining a regimen, these events should be viewed as a potential adherence concern and an opportunity for the practitioner to intervene. Options should be discussed with the patient regarding dosing adjustments, use of adjunctive therapies, or stopping, reassessing, and potentially switching to a more favorable regimen.
The importance of a simplified HAART regimen cannot be overstated. Although it may seem intuitive that higher pill burdens may be associated with decreased adherence, this premise has not proven to be the case in various studies (9) . Convenience, in terms of meals and other factors, may be greater determinants of adherence than pill burden alone. In addition, proper thought must be taken regarding the effect of dosing frequency and dosing interval on adherence. Ostrop and colleagues (20) noted that among 100 patients interviewed during their study, the primary cause for decreased adherence was difficulty in remembering, followed by inconvenient dosing around meals. Considerations must be made for the dosing frequency, number of pills, potential for side effects, and food requirements (28, 60) . These concerns are of greater importance in an older population because of the higher number of concurrent medications and comorbidities and the greater likelihood of adverse drug reactions. Their importance is demonstrated in a study by Akshita et al. (68) , which reported that the frequency of adverse drug reactions increased according to age. An increased number of prescribed medicines also might help to explain increased adverse drug reactions among the elderly (68) .
Several researchers have used various mechanical devices to improve antiretroviral adherence. Mechanical assistance can be provided through use of written schedules, pillboxes, alarm clocks, pagers, and other reminders (9, 15, 69) . Other adherence interventions have included mass media campaigns (70) , videos/booklets created by people living with HIV (71), automated telephone communication technology (72) , and social case management, including psychologic evaluation and treatment to improve adherence (73) . DOT has been used to ensure adherence; however, this method is labor-intensive, expensive, and not necessarily well suited to most patients.
SUMMARY
Improvements in survival with HIV disease can be attributed to various factors, including earlier diagnosis, treatment of opportunistic infections, and improved antiretroviral therapy. The benefits of improved therapies only can be obtained through strict adherence to these potentially complex regimens. This holds true for older
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HIV patients in that they often are diagnosed later in their disease course than younger patients and typically take more medications for concomitant therapy. The growing armamentarium of antiretroviral therapies has proven effective in decreasing HIV replication; however, the likelihood of medication side effects and potentially complex regimens have challenged the ability of patients to adhere to the regimens. Furthermore, no universally accepted gold standard exists for measuring antiretroviral adherence among older patients. Various methods, including self-report, pill count, and electronic monitoring, each have major advantages and significant disadvantages. Multiple methods are needed to assess adherence adequately. Studies of treatment behavior among older patients in other disease states have noted various factors that may affect adherence, including polypharmacy, knowledge of the regimen, and patient-physician communication. In addition, studies of younger HIV-infected adults have noted several factors that may influence antiretroviral adherence, including the following: depression, current drug or alcohol use, medication side effects, and convenient access to medications. To improve patient adherence, a combination of patient-specific, medicationspecific, and clinician-focused strategies should be used. Clinicians must work in concert with patients to select effective regimens, to identify potential adherence concerns, and to adjust regimens as necessary. This is particularly salient for older patients who may be taking multiple medications for other medical ailments. It is also important to provide additional support for patients who may be at increased risk for lower adherence, particularly patients who are depressed or have active substance abuse issues. Care for these patients should be coordinated with mental health professionals, social workers, case managers, and other integral member of the health care team.
Research Opportunities
Many opportunities for future research are evident in the study of antiretroviral adherence behavior among older HIV-infected patients. In particular, a great need exists to investigate the impact of comorbid conditions and use of concurrent medications on adherence behavior of older patients with HIV. Additionally, there is currently little research regarding whether adherence patterns may change in older patients as they approach elderly status or move from one age cohort to another. It also would be of great value to consider to what extent adherence is influenced by confidence in health care providers, older patients' own knowledge regarding HIV and drugs used to treat it, previous experience with drugs, support from family and friends, and ease of communication with health care professionals. Psychologic research to identify better methods of predicting medication adherence may serve to inform medical decisionmaking regarding optimal treatments. Furthermore, the association of inadequate access to medications or interruption of an individual patient's pattern as a result of the incidental missing of medications should be an area of consideration. Effective intervention strategies that affect adherence also should be included in topics for future research agenda. For instance, methods such as automated telephone calls with nurse follow-up may be an effective strategy for improving HIV medication adherence in older patients and for decreasing the complications of nonadherence. Finally, the role of alternative medicines and their effect on adherence should be further investigated among older patients using antiretroviral medication.
